Compile Data Set for Download or QSAR

Found 3 hits with Last Name = 'taganov' and Initial = 'k'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
UDP-3-O-acyl-N-acetylglucosamine deacetylase ()	BDBM50200120 (CHEMBL260091 | CHIR-090 | US10875832, Compound ChI...) Show SMILES C[C@@H](O)[C@H](NC(=O)c1ccc(cc1)C#Cc1ccc(CN2CCOCC2)cc1)C(=O)NO |r| Show InChI InChI=1S/C24H27N3O5/c1-17(28)22(24(30)26-31)25-23(29)21-10-8-19(9-11-21)3-2-18-4-6-20(7-5-18)16-27-12-14-32-15-13-27/h4-11,17,22,28,31H,12-16H2,1H3,(H,25,29)(H,26,30)/t17-,22+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid PDB UniChem	US Patent	n/a	n/a	<1	n/a	n/a	n/a	n/a	n/a	n/a
FORGE THERAPEUTICS, INC. US Patent					Assay Description LpxC inhibition assays were performed using liquid chromatography with tandem mass spectrometry. Assays were performed, in duplicate, in opaque, 96-w...				US Patent US10875832 (2020) BindingDB Entry DOI: 10.7270/Q2SX6H9K
					More data for this Ligand-Target Pair
UDP-3-O-acyl-N-acetylglucosamine deacetylase ()	BDBM476342 (US10875832, Compound 97) Show SMILES Oc1c(CNc2ccc(cc2)C#CC#Cc2ccc(cc2)C(=O)N2CCOCC2)nc[nH]c1=O Show InChI InChI=1S/C26H22N4O4/c31-24-23(28-18-29-25(24)32)17-27-22-11-7-20(8-12-22)4-2-1-3-19-5-9-21(10-6-19)26(33)30-13-15-34-16-14-30/h5-12,18,27,31H,13-17H2,(H,28,29,32)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
FORGE THERAPEUTICS, INC. US Patent					Assay Description LpxC inhibition assays were performed using liquid chromatography with tandem mass spectrometry. Assays were performed, in duplicate, in opaque, 96-w...				US Patent US10875832 (2020) BindingDB Entry DOI: 10.7270/Q2SX6H9K
					More data for this Ligand-Target Pair
UDP-3-O-acyl-N-acetylglucosamine deacetylase ()	BDBM476343 (US10875832, Compound 98) Show SMILES Oc1c(CNc2ccc(cc2)C#Cc2ccc(CN3CCOCC3)cc2)nc[nH]c1=O Show InChI InChI=1S/C24H24N4O3/c29-23-22(26-17-27-24(23)30)15-25-21-9-7-19(8-10-21)2-1-18-3-5-20(6-4-18)16-28-11-13-31-14-12-28/h3-10,17,25,29H,11-16H2,(H,26,27,30)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
FORGE THERAPEUTICS, INC. US Patent					Assay Description LpxC inhibition assays were performed using liquid chromatography with tandem mass spectrometry. Assays were performed, in duplicate, in opaque, 96-w...				US Patent US10875832 (2020) BindingDB Entry DOI: 10.7270/Q2SX6H9K
					More data for this Ligand-Target Pair